Stock Analysis on Net

Baxter International Inc. (NYSE:BAX)

This company has been moved to the archive! The financial data has not been updated since August 4, 2016.

Analysis of Solvency Ratios 

Microsoft Excel

Solvency Ratios (Summary)

Baxter International Inc., solvency ratios

Microsoft Excel
Dec 31, 2015 Dec 31, 2014 Dec 31, 2013 Dec 31, 2012 Dec 31, 2011
Debt Ratios
Debt to equity 0.74 1.15 1.08 0.85 0.79
Debt to capital 0.42 0.53 0.52 0.46 0.44
Debt to assets 0.31 0.36 0.35 0.29 0.27
Financial leverage 2.37 3.19 3.06 2.94 2.90
Coverage Ratios
Interest coverage 3.93 15.60 17.45 26.57 31.53
Fixed charge coverage 2.30 6.85 7.91 10.17 10.52

Based on: 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31).

Solvency ratio Description The company
Debt to equity ratio A solvency ratio calculated as total debt divided by total shareholders’ equity. Baxter International Inc. debt to equity ratio deteriorated from 2013 to 2014 but then improved from 2014 to 2015 exceeding 2013 level.
Debt to capital ratio A solvency ratio calculated as total debt divided by total debt plus shareholders’ equity. Baxter International Inc. debt to capital ratio deteriorated from 2013 to 2014 but then improved from 2014 to 2015 exceeding 2013 level.
Debt to assets ratio A solvency ratio calculated as total debt divided by total assets. Baxter International Inc. debt to assets ratio deteriorated from 2013 to 2014 but then improved from 2014 to 2015 exceeding 2013 level.
Financial leverage ratio A solvency ratio calculated as total assets divided by total shareholders’ equity. Baxter International Inc. financial leverage ratio increased from 2013 to 2014 but then decreased significantly from 2014 to 2015.

Solvency ratio Description The company
Interest coverage ratio A solvency ratio calculated as EBIT divided by interest payments. Baxter International Inc. interest coverage ratio deteriorated from 2013 to 2014 and from 2014 to 2015.
Fixed charge coverage ratio A solvency ratio calculated as earnings before fixed charges and tax divided by fixed charges. Baxter International Inc. fixed charge coverage ratio deteriorated from 2013 to 2014 and from 2014 to 2015.

Debt to Equity

Baxter International Inc., debt to equity calculation, comparison to benchmarks

Microsoft Excel
Dec 31, 2015 Dec 31, 2014 Dec 31, 2013 Dec 31, 2012 Dec 31, 2011
Selected Financial Data (US$ in millions)
Short-term debt 1,775 913 181 27 256
Current maturities of long-term debt and lease obligations 810 786 859 323 190
Long-term debt and lease obligations, excluding current maturities 3,935 7,606 8,126 5,580 4,749
Total debt 6,520 9,305 9,166 5,930 5,195
 
Total Baxter shareholders’ equity 8,846 8,120 8,463 6,938 6,585
Solvency Ratio
Debt to equity1 0.74 1.15 1.08 0.85 0.79
Benchmarks
Debt to Equity, Competitors2
Abbott Laboratories
Cigna Group
CVS Health Corp.
Elevance Health Inc.
Humana Inc.
Intuitive Surgical Inc.
Medtronic PLC
UnitedHealth Group Inc.

Based on: 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31).

1 2015 Calculation
Debt to equity = Total debt ÷ Total Baxter shareholders’ equity
= 6,520 ÷ 8,846 = 0.74

2 Click competitor name to see calculations.

Solvency ratio Description The company
Debt to equity ratio A solvency ratio calculated as total debt divided by total shareholders’ equity. Baxter International Inc. debt to equity ratio deteriorated from 2013 to 2014 but then improved from 2014 to 2015 exceeding 2013 level.

Debt to Capital

Baxter International Inc., debt to capital calculation, comparison to benchmarks

Microsoft Excel
Dec 31, 2015 Dec 31, 2014 Dec 31, 2013 Dec 31, 2012 Dec 31, 2011
Selected Financial Data (US$ in millions)
Short-term debt 1,775 913 181 27 256
Current maturities of long-term debt and lease obligations 810 786 859 323 190
Long-term debt and lease obligations, excluding current maturities 3,935 7,606 8,126 5,580 4,749
Total debt 6,520 9,305 9,166 5,930 5,195
Total Baxter shareholders’ equity 8,846 8,120 8,463 6,938 6,585
Total capital 15,366 17,425 17,629 12,868 11,780
Solvency Ratio
Debt to capital1 0.42 0.53 0.52 0.46 0.44
Benchmarks
Debt to Capital, Competitors2
Abbott Laboratories
Cigna Group
CVS Health Corp.
Elevance Health Inc.
Humana Inc.
Intuitive Surgical Inc.
Medtronic PLC
UnitedHealth Group Inc.

Based on: 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31).

1 2015 Calculation
Debt to capital = Total debt ÷ Total capital
= 6,520 ÷ 15,366 = 0.42

2 Click competitor name to see calculations.

Solvency ratio Description The company
Debt to capital ratio A solvency ratio calculated as total debt divided by total debt plus shareholders’ equity. Baxter International Inc. debt to capital ratio deteriorated from 2013 to 2014 but then improved from 2014 to 2015 exceeding 2013 level.

Debt to Assets

Baxter International Inc., debt to assets calculation, comparison to benchmarks

Microsoft Excel
Dec 31, 2015 Dec 31, 2014 Dec 31, 2013 Dec 31, 2012 Dec 31, 2011
Selected Financial Data (US$ in millions)
Short-term debt 1,775 913 181 27 256
Current maturities of long-term debt and lease obligations 810 786 859 323 190
Long-term debt and lease obligations, excluding current maturities 3,935 7,606 8,126 5,580 4,749
Total debt 6,520 9,305 9,166 5,930 5,195
 
Total assets 20,975 25,917 25,869 20,390 19,073
Solvency Ratio
Debt to assets1 0.31 0.36 0.35 0.29 0.27
Benchmarks
Debt to Assets, Competitors2
Abbott Laboratories
Cigna Group
CVS Health Corp.
Elevance Health Inc.
Humana Inc.
Intuitive Surgical Inc.
Medtronic PLC
UnitedHealth Group Inc.

Based on: 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31).

1 2015 Calculation
Debt to assets = Total debt ÷ Total assets
= 6,520 ÷ 20,975 = 0.31

2 Click competitor name to see calculations.

Solvency ratio Description The company
Debt to assets ratio A solvency ratio calculated as total debt divided by total assets. Baxter International Inc. debt to assets ratio deteriorated from 2013 to 2014 but then improved from 2014 to 2015 exceeding 2013 level.

Financial Leverage

Baxter International Inc., financial leverage calculation, comparison to benchmarks

Microsoft Excel
Dec 31, 2015 Dec 31, 2014 Dec 31, 2013 Dec 31, 2012 Dec 31, 2011
Selected Financial Data (US$ in millions)
Total assets 20,975 25,917 25,869 20,390 19,073
Total Baxter shareholders’ equity 8,846 8,120 8,463 6,938 6,585
Solvency Ratio
Financial leverage1 2.37 3.19 3.06 2.94 2.90
Benchmarks
Financial Leverage, Competitors2
Abbott Laboratories
Cigna Group
CVS Health Corp.
Elevance Health Inc.
Humana Inc.
Intuitive Surgical Inc.
Medtronic PLC
UnitedHealth Group Inc.

Based on: 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31).

1 2015 Calculation
Financial leverage = Total assets ÷ Total Baxter shareholders’ equity
= 20,975 ÷ 8,846 = 2.37

2 Click competitor name to see calculations.

Solvency ratio Description The company
Financial leverage ratio A solvency ratio calculated as total assets divided by total shareholders’ equity. Baxter International Inc. financial leverage ratio increased from 2013 to 2014 but then decreased significantly from 2014 to 2015.

Interest Coverage

Baxter International Inc., interest coverage calculation, comparison to benchmarks

Microsoft Excel
Dec 31, 2015 Dec 31, 2014 Dec 31, 2013 Dec 31, 2012 Dec 31, 2011
Selected Financial Data (US$ in millions)
Net income attributable to Baxter 968 2,497 2,012 2,326 2,224
Add: Net income attributable to noncontrolling interest 32
Less: Income from discontinued operations, net of tax 575 551
Add: Income tax expense 35 493 537 563 553
Add: Interest expense 146 167 155 113 92
Earnings before interest and tax (EBIT) 574 2,606 2,704 3,002 2,901
Solvency Ratio
Interest coverage1 3.93 15.60 17.45 26.57 31.53
Benchmarks
Interest Coverage, Competitors2
Abbott Laboratories
Cigna Group
CVS Health Corp.
Elevance Health Inc.
Humana Inc.
Intuitive Surgical Inc.
Medtronic PLC
UnitedHealth Group Inc.

Based on: 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31).

1 2015 Calculation
Interest coverage = EBIT ÷ Interest expense
= 574 ÷ 146 = 3.93

2 Click competitor name to see calculations.

Solvency ratio Description The company
Interest coverage ratio A solvency ratio calculated as EBIT divided by interest payments. Baxter International Inc. interest coverage ratio deteriorated from 2013 to 2014 and from 2014 to 2015.

Fixed Charge Coverage

Baxter International Inc., fixed charge coverage calculation, comparison to benchmarks

Microsoft Excel
Dec 31, 2015 Dec 31, 2014 Dec 31, 2013 Dec 31, 2012 Dec 31, 2011
Selected Financial Data (US$ in millions)
Net income attributable to Baxter 968 2,497 2,012 2,326 2,224
Add: Net income attributable to noncontrolling interest 32
Less: Income from discontinued operations, net of tax 575 551
Add: Income tax expense 35 493 537 563 553
Add: Interest expense 146 167 155 113 92
Earnings before interest and tax (EBIT) 574 2,606 2,704 3,002 2,901
Add: Operating lease rent expense 184 250 214 202 203
Earnings before fixed charges and tax 758 2,856 2,918 3,204 3,104
 
Interest expense 146 167 155 113 92
Operating lease rent expense 184 250 214 202 203
Fixed charges 330 417 369 315 295
Solvency Ratio
Fixed charge coverage1 2.30 6.85 7.91 10.17 10.52
Benchmarks
Fixed Charge Coverage, Competitors2
Abbott Laboratories
Cigna Group
CVS Health Corp.
Elevance Health Inc.
Humana Inc.
Intuitive Surgical Inc.
Medtronic PLC
UnitedHealth Group Inc.

Based on: 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31).

1 2015 Calculation
Fixed charge coverage = Earnings before fixed charges and tax ÷ Fixed charges
= 758 ÷ 330 = 2.30

2 Click competitor name to see calculations.

Solvency ratio Description The company
Fixed charge coverage ratio A solvency ratio calculated as earnings before fixed charges and tax divided by fixed charges. Baxter International Inc. fixed charge coverage ratio deteriorated from 2013 to 2014 and from 2014 to 2015.